Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:948304.
doi: 10.1155/2015/948304. Epub 2015 Dec 6.

Low Dose Perioperative Intravenous Tranexamic Acid in Patients Undergoing Total Knee Arthroplasty: A Double-Blind Randomized Placebo Controlled Clinical Trial

Mahdi Motififard  1 , Mohammad Ali Tahririan  1 , Mehdi Saneie  1 , Sajad Badiei  2 , Amin Nemati  2
Affiliations

Low Dose Perioperative Intravenous Tranexamic Acid in Patients Undergoing Total Knee Arthroplasty: A Double-Blind Randomized Placebo Controlled Clinical Trial

Mahdi Motififard et al. J Blood Transfus. 2015.

Abstract

Background and Objectives. The null hypothesis of this study was that TA has no effect on postsurgical bleeding in patients undergoing TKA. Methods. This study was a double-blind randomized trial. In the first group (T) patients received 500 mg of intravenous Tranexamic acid (TA) twice (once preoperatively and once 3 hours postoperatively) and in the second group (P) they received slow infusion of normal saline as placebo. The primary outcome of the study was the level of Hb 48 hours after surgery. Results. Hb levels 48 hours after surgery as the primary outcome were 10.92 ± 0.97 and 10.23 ± 0.98 (g/dL) in groups T and P, respectively, and the difference was statistically significant (P = 0.001). Statistically significant differences were also observed in Hb levels 6 and 24 hours after surgery, the drain output 48 hours after surgery, and the number of units of packed cells transfused between study groups (P < 0.05). There was no significant difference in duration of hospitalization between the study groups (P = n.s.). Conclusions. The low dose perioperative intravenous TA significantly reduces blood loss, requirement for blood transfusion, and drain output in patients undergoing TKA. However, duration of hospitalization did not change significantly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participants' flow diagram.
See this image and copyright information in PMC

References

    1. Bierbaum B. E., Hill C., Callaghan J. J., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. The Journal of Bone & Joint Surgery—American Volume. 1999;81(1):2–10. - PubMed
    1. Noticewala M. S., Nyce J. D., Wang W., Geller J. A., Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. The Journal of Arthroplasty. 2012;27(6):961–967. doi: 10.1016/j.arth.2011.10.008. - DOI - PubMed
    1. Stokes M. E., Ye X., Shah M., et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Services Research. 2011;11, article 135 doi: 10.1186/1472-6963-11-135. - DOI - PMC - PubMed
    1. Tuttle J. R., Ritterman S. A., Cassidy D. B., Anazonwu W. A., Froehlich J. A., Rubin L. E. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. The Journal of Arthroplasty. 2014;29(8):1512–1515. doi: 10.1016/j.arth.2014.01.031. - DOI - PubMed
    1. Gibbons C. E. R., Solan M. C., Ricketts D. M., Patterson M. Cryotherapy compared with Robert Jones bandage after total knee replacement: a prospective randomized trial. International Orthopaedics. 2001;25(4):250–252. doi: 10.1007/s002640100227. - DOI - PMC - PubMed

LinkOut - more resources